| Bryan Armando Mejia, MD | |
|
220 E. Harris, San Angelo, TX 76903 | |
| (325) 481-2285 | |
| Not Available |
| Full Name | Bryan Armando Mejia |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 220 E. Harris, San Angelo, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114107828 | NPI | - | NPPES |
| 335797YKRY | Other | TX | MEDICARE PTAN |
| 333978002 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | P9224 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Shannon Medical Center | San angelo, TX | Hospital |
| Entity Name | Shannon Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770587149 PECOS PAC ID: 0840103727 Enrollment ID: O20031222000702 |
News Archive
As the COVID-19 pandemic and its far-reaching implications continue to unfold globally and disrupt our normal way of life, scientists and researchers are racing to find an appropriate vaccine or therapeutic drug. This process involves understanding how the virus interacts with the host cell, the dynamics of the host immune response, and the eventual outcome.
"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.
New research from Boston Children's Hospital could potentially change how doctors approach two blinding diseases: 'Wet' age-related macular degeneration (AMD), the leading cause of blindness in the elderly, and macular telangiectasia (MacTel).
Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.
› Verified 2 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
As the COVID-19 pandemic and its far-reaching implications continue to unfold globally and disrupt our normal way of life, scientists and researchers are racing to find an appropriate vaccine or therapeutic drug. This process involves understanding how the virus interacts with the host cell, the dynamics of the host immune response, and the eventual outcome.
"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.
New research from Boston Children's Hospital could potentially change how doctors approach two blinding diseases: 'Wet' age-related macular degeneration (AMD), the leading cause of blindness in the elderly, and macular telangiectasia (MacTel).
Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.
› Verified 2 days ago
| Entity Name | Concho Valley Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225737539 PECOS PAC ID: 9638536840 Enrollment ID: O20230602001767 |
News Archive
As the COVID-19 pandemic and its far-reaching implications continue to unfold globally and disrupt our normal way of life, scientists and researchers are racing to find an appropriate vaccine or therapeutic drug. This process involves understanding how the virus interacts with the host cell, the dynamics of the host immune response, and the eventual outcome.
"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.
New research from Boston Children's Hospital could potentially change how doctors approach two blinding diseases: 'Wet' age-related macular degeneration (AMD), the leading cause of blindness in the elderly, and macular telangiectasia (MacTel).
Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Armando Mejia, MD 3555 Knickerbocker Rd, San Angelo, TX 76904-7610 Ph: (325) 949-9555 | Bryan Armando Mejia, MD 220 E. Harris, San Angelo, TX 76903 Ph: (325) 481-2285 |
News Archive
As the COVID-19 pandemic and its far-reaching implications continue to unfold globally and disrupt our normal way of life, scientists and researchers are racing to find an appropriate vaccine or therapeutic drug. This process involves understanding how the virus interacts with the host cell, the dynamics of the host immune response, and the eventual outcome.
"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.
New research from Boston Children's Hospital could potentially change how doctors approach two blinding diseases: 'Wet' age-related macular degeneration (AMD), the leading cause of blindness in the elderly, and macular telangiectasia (MacTel).
Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.
› Verified 2 days ago
Dr. Jesse L Jurado, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3501 Executive Dr, San Angelo, TX 76904 Phone: 325-949-5081 Fax: 325-224-4284 | |
Dennis Durham, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3501 Knickerbocker Rd, San Angelo, TX 76904 Phone: 325-947-6063 Fax: 325-947-6189 | |
Charles M Jones, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 E Beauregard Ave, San Angelo, TX 76903 Phone: 325-481-2198 Fax: 325-659-0180 | |
David R Delaplane, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3350 Executive Dr Ste 108, San Angelo, TX 76904 Phone: 325-245-4500 Fax: 325-245-4040 | |
Dr. Kai M Sun, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3350 Executive Dr, Suite 100, San Angelo, TX 76904 Phone: 325-245-4501 | |
Javier Leoncio Baez Presser, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 E Harris Ave, San Angelo, TX 76903 Phone: 325-481-6410 | |
Fernando Alcocer-aguilar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 E. Beauregard, San Angelo, TX 76903 Phone: 325-658-1511 Fax: 325-481-2166 |